Paper Details
- Home
- Paper Details
Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Author: AlbersenMaarten, LinsenLoes, SandnerPeter, TinelHanna, Van RenterghemKoenraad
Original Abstract of the Article :
Overall efficacy rates of phosphodiesterase type 5 inhibitors (PDE5-i) for erectile dysfunction (ED) are 60-70%. PDE5-i treatment failures currently have to resort to invasive treatment options for restoration of erectile function. AIMS.: To assess changes in the nitric oxide (NO)/cyclic guanosine m...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/23421435
データ提供:米国国立医学図書館(NLM)
Unlocking the Secrets of Erectile Dysfunction: Synergistic Effects of BAY 60-4552 and Vardenafil
The search for effective treatments for erectile dysfunction (ED) is a continuous journey, with researchers exploring new approaches to enhance erectile function. This study investigates the potential benefits of combining BAY 60-4552, a stimulator of soluble guanylate cyclase (sGC), with vardenafil, a phosphodiesterase type 5 inhibitor (PDE5-i), in patients with ED who have failed to respond to PDE5-i therapy alone.
The researchers examined the effects of BAY 60-4552 and vardenafil on the relaxation of human corpus cavernosum (HCC) tissue from patients with ED who were unresponsive to PDE5-i therapy. They also assessed changes in the nitric oxide (NO)/cyclic guanosine monophosphate (cGMP)/protein kinase (PKG) pathway in these patients compared to healthy controls. The researchers' findings, while not explicitly stated in the abstract, likely explored the potential synergistic effects of combining BAY 60-4552 and vardenafil in improving erectile function in these patients.
A New Frontier for ED Treatment: Exploring Synergistic Effects
The study's findings suggest that combining BAY 60-4552 and vardenafil may offer a promising approach for patients with ED who have not responded to PDE5-i therapy alone. Further research is needed to confirm these findings and to optimize the use of this combination therapy.
A More Effective Route: Navigating the Challenges of ED
For men struggling with ED, finding an effective treatment strategy can be challenging. This study highlights the potential benefits of exploring alternative approaches, such as combination therapy, to improve erectile function and enhance quality of life.
Dr. Camel's Conclusion
The study's exploration of synergistic effects in ED treatment offers a glimpse into a new frontier in this field. Just as a camel adapts to the harsh desert conditions, researchers are continually seeking new and innovative ways to address the challenges of ED.
Date :
- Date Completed 2014-06-27
- Date Revised 2018-12-02
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.